{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:59:55Z","timestamp":1781283595161,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.biopha.2023.114488","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T12:33:17Z","timestamp":1678451597000},"page":"114488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Exogenous hydrogen sulfide (H2S) exerts therapeutic potential in triple-negative breast cancer by affecting cell cycle and DNA replication pathway"],"prefix":"10.1016","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8716-9516","authenticated-orcid":false,"given":"Xiaoyue","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.114488_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pharmthera.2019.02.006","article-title":"Recent therapeutic trends and promising targets in triple negative breast cancer","volume":"199","author":"Hwang","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2023.114488_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.biopha.2023.114488_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/app12115554","article-title":"New achievements for the treatment of triple-negative breast cancer","volume":"12","author":"Catalano","year":"2022","journal-title":"Appl. Sci."},{"key":"10.1016\/j.biopha.2023.114488_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1206-z","article-title":"STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review","volume":"38","author":"Qin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2023.114488_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/BCTT.S348060","article-title":"Treatment strategies against triple-negative breast cancer: an updated review","volume":"14","author":"Maqbool","year":"2022","journal-title":"Breast Cancer-Targets Ther."},{"key":"10.1016\/j.biopha.2023.114488_bib6","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1158\/1078-0432.CCR-19-3545","article-title":"FDA approval summary: atezolizumab plus paclitaxel protein-bound for the treatment of patients with advanced or metastatic TNBC whose tumors express PD-L1","volume":"26","author":"Narayan","year":"2020","journal-title":"Clin. CANCER Res."},{"key":"10.1016\/j.biopha.2023.114488_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.46883\/ONC.2021.3505.0249","article-title":"Novel therapies for metastatic triple-negative breast cancer: spotlight on immunotherapy and antibody-drug conjugates","volume":"35","author":"Nagayama","year":"2021","journal-title":"Oncology"},{"key":"10.1016\/j.biopha.2023.114488_bib8","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa2028485","article-title":"Sacituzumab govitecan in metastatic triple-negative breast cancer","volume":"384","author":"Bardia","year":"2021","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.114488_bib9","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1096\/fj.02-0211hyp","article-title":"Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter","volume":"16","author":"Wang","year":"2002","journal-title":"Faseb J."},{"key":"10.1016\/j.biopha.2023.114488_bib10","doi-asserted-by":"crossref","unstructured":"Be\u0142towski, J.Synthesis, Metabolism, and Signaling Mechanisms of Hydrogen Sulfide: An Overview. Methods Mol Biol 2007, 1\u20138, doi:10.1007\/978\u20131-4939\u20139528-8_1 (2019).","DOI":"10.1007\/978-1-4939-9528-8_1"},{"key":"10.1016\/j.biopha.2023.114488_bib11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.taap.2011.09.026","article-title":"Hydrogen sulfide mediates the anti-survival effect of sulforaphane on human prostate cancer cells","volume":"257","author":"Pei","year":"2011","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.biopha.2023.114488_bib12","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1007\/s11064-009-0006-9","article-title":"Hydrogen sulfide attenuates neuronal injury induced by vascular dementia via inhibiting apoptosis in rats","volume":"34","author":"Zhang","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2023.114488_bib13","unstructured":"Fiaz et al. Exogenous Hydrogen Sulfide (H2S) Reduces Blood Pressure and Prevents the Progression of Diabetic Nephropathy in Spontaneously Hypertensive Rats. Renal Failure (2012)."},{"key":"10.1016\/j.biopha.2023.114488_bib14","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7150\/ijbs.3632","article-title":"Hydrogen sulfide mitigates cardiac remodeling during myocardial infarction via improvement of angiogenesis","volume":"8","author":"Natia","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2023.114488_bib15","first-page":"51","article-title":"Hypoxic pulmonary vasodilation: a paradigm shift with a hydrogen sulfide mechanism","volume":"298","author":"Olson","year":"2010","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.biopha.2023.114488_bib16","doi-asserted-by":"crossref","unstructured":"Zhang, L. et al. An Anticancer Role of Hydrogen Sulfide in Human Gastric Cancer Cells. Oxid Med Cell Longev 2015, 636410, doi:10.1155\/2015\/636410 (2015).","DOI":"10.1155\/2015\/636410"},{"key":"10.1016\/j.biopha.2023.114488_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.phrs.2016.10.019","article-title":"ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo","volume":"114","author":"De Cicco","year":"2016","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2023.114488_bib18","first-page":"2969","article-title":"Anticancer effect of exogenous hydrogen sulfide in cisplatinresistant A549\/DDP cells","volume":"39","author":"Ma","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2023.114488_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/CBI20090368","article-title":"Hydrogen sulfide induces human colon cancer cell proliferation: role of Akt, ERK and p21","volume":"34","author":"Cai","year":"2010","journal-title":"Cell Biol. Int"},{"key":"10.1016\/j.biopha.2023.114488_bib20","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3892\/or.2016.5014","article-title":"Exogenous hydrogen sulfide exerts proliferation, anti-apoptosis, migration effects and accelerates cell cycle progression in multiple myeloma cells via activating the Akt pathway","volume":"36","author":"Zheng","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2023.114488_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2023.114488_bib22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nbt.3122","article-title":"StringTie enables improved reconstruction of a transcriptome from RNA-seq reads","volume":"33","author":"Pertea","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2023.114488_bib23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.12688\/f1000research.2-188.v1","article-title":"Thousands of exon skipping events differentiate among splicing patterns in sixteen human tissues","volume":"2","author":"Florea","year":"2013","journal-title":"F1000Research"},{"key":"10.1016\/j.biopha.2023.114488_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2010-11-2-r14","article-title":"Gene ontology analysis for RNA-seq: accounting for selection bias","volume":"11","author":"Young","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.biopha.2023.114488_bib25","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1093\/bioinformatics\/bti430","article-title":"Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary","volume":"21","author":"Mao","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2023.114488_bib26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nbt.3122","article-title":"StringTie enables improved reconstruction of a transcriptome from RNA-seq reads","volume":"33","author":"Pertea","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2023.114488_bib27","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.2-188.v1","article-title":"Thousands of exon skipping events differentiate among splicing patterns in sixteen human tissues","volume":"2","author":"Florea","year":"2013","journal-title":"F1000Research"},{"key":"10.1016\/j.biopha.2023.114488_bib28","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2023.114488_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev.biochem.72.121801.161720","article-title":"Mechanisms of alternative pre-messenger RNA splicing","volume":"72","author":"Black","year":"2003","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.biopha.2023.114488_bib30","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2023.114488_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-94-007-4572-8_9","article-title":"The Pol \u03b1-primase complex","volume":"62","author":"Pellegrini","year":"2012","journal-title":"Sub-Cell. Biochem."},{"key":"10.1016\/j.biopha.2023.114488_bib32","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.3892\/or.2015.4248","article-title":"Exogenous hydrogen sulfide promotes C6 glioma cell growth through activation of the p38 MAPK\/ERK1\/2-COX-2 pathways","volume":"34","author":"Zhen","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2023.114488_bib33","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.3892\/or.2016.4691","article-title":"Hydrogen sulfide promotes cell proliferation of oral cancer through activation of the COX2\/AKT\/ERK1\/2 axis","volume":"35","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2023.114488_bib34","article-title":"H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S","volume":"6","author":"Ma","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114488_bib35","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1515\/hsz-2015-0148","article-title":"Exogenous hydrogen sulfide exhibits anti-cancer effects though p38 MAPK signaling pathway in C6 glioma cells","volume":"396","author":"Zhao","year":"2015","journal-title":"Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114488_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/ars.2017.7058","article-title":"A review of hydrogen sulfide synthesis, metabolism, and measurement: is modulation of hydrogen sulfide a novel therapeutic for cancer","volume":"31","author":"Cao","year":"2019","journal-title":"Antioxid. Redox Signal"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223002767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223002767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:24:38Z","timestamp":1781281478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223002767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":36,"alternative-id":["S0753332223002767"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114488","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exogenous hydrogen sulfide (H2S) exerts therapeutic potential in triple-negative breast cancer by affecting cell cycle and DNA replication pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114488"}}